Product Reports Resources Pricing Login Book a demo

UroMems

Biotech & Life Sciences · Eybens, France · Founded 2011

UroMems is a pioneering startup that is revolutionizing the medical industry with its innovative technology. The company specializes in developing smart, active implantable medical devices designed to treat stress urinary incontinence (SUI), a condition that affects both men and women. SUI can significantly impact a person's quality of life, and UroMems' technology aims to provide an efficient and personalized solution to this problem. The company's flagship product, UroActive™, is a testament to its commitment to leveraging the latest technological advancements in embedded systems and micro-technologies. This product is designed to automatically adjust to each patient's unique needs, providing an improved experience and a better quality of life. UroMems operates in the global medical device market, serving a broad range of clients, including hospitals, clinics, and healthcare providers. The company's business model revolves around the development, production, and sale of its innovative medical devices. The revenue is generated from the sales of these devices to healthcare providers who then offer the treatment to their patients. Founded in 2011 by a team of experts with multiple patents to their name, UroMems has positioned itself as a leader in the development of smart implantable medical devices. The company's groundbreaking technology and commitment to improving patient outcomes underscore its potential for growth in the medical device industry. Keywords: UroMems, Stress Urinary Incontinence, Medical Devices, Implantable Devices, UroActive™, Healthcare, Embedded Systems, Micro-Technologies, Quality of Life, Personalized Treatment.

Investors

16 investors on UroMems's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
European Innovation Council
Series A 13 investors entered at this stage
Wellington Partners
CEA Investissement
Bpifrance
CITA Investissement
b2venture
Financiere Arbevel
BNP Paribas
Crédit Agricole
Caisse d'Epargne
Supernova Invest
Banque Populaire Atlantique
Hil-Invent
EIC Fund
Series B+ 2 investors entered at this stage
Crédit Mutuel Innovation
Ajax Health

Global footprint

Where UroMems has talent and traffic

Workforce by country
4 countries with
team presence
🇫🇷 France87.5%
🇺🇸 United States9.7%
🇱🇺 Luxembourg1.4%
🇩🇪 Germany1.4%
4 countries shown

Talent graph

The shape of UroMems's talent

Dealroom maps UroMems's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 team members profilednamed & role-tagged by Dealroom
90 employeestotal headcount
5 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock UroMems's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about UroMems

An AI-synthesized read of the highest-engagement posts about UroMems on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See UroMems on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.